AI 90日予測
保留
7日間
30日
90日
AI信頼度: 23% スピアマン相関
5月 13, 2026
価格チャート
チャートを読み込み中...
主要統計
時価総額
$2.45B
PBR（株価純資産倍率）
3.81x
ROE
-32.2%
収益
$10M
流動比率
22.13x
D/Eレシオ
0.09x
について Relay Therapeutics, Inc.
Relay Therapeutics, Inc. (RLAY) Life Sciencesセクターで事業を展開、具体的にはBiological Products, (No Diagnostic Substances)業界内で. .
We do not have any company description for Relay Therapeutics, Inc. at the moment.
Biological Products, (No Diagnostic Substances) 同業他社
| 企業 | ティッカー | AIシグナル | 時価総額 | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $179M | -x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $1M | -x |
| Arcellx, Inc. | ACLX | ██% | $6.73B | -x |
| Alpha Cognition Inc. | ACOG | ██% | $119M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13.2x |
| Adma Biologics, Inc. | ADMA | ██% | $1.95B | 11.8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.18B | -x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1.8x |
| Agenus Inc | AGEN | ██% | $133M | 2.1x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $2M | -x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $240M | -x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $40M | -x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $794M | -x |
| Alvotech | ALVO | ██% | $1.11B | -x |
| Amgen Inc | AMGN | ██% | $181.50B | 23.3x |
| Apogee Therapeutics, Inc. | APGE | ██% | $6.21B | -x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $50.30B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $330M | -x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $516M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0.2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $84M | -x |
| Atyr Pharma Inc | ATYR | ██% | $52M | -x |
| Aura Biosciences, Inc. | AURA | ██% | $875M | -x |
| Autolus Therapeutics Plc | AUTL | ██% | $426M | -x |
| Anavex Life Sciences … | AVXL | ██% | $284M | -x |
| Bioatla, Inc. | BCAB | ██% | $8M | -x |
| Biocardia, Inc. | BCDA | ██% | $12M | -x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $8M | -x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.24B | -x |
| Black Diamond Therapeutics, … | BDTX | ██% | $162M | -x |
| Beam Therapeutics Inc. | BEAM | ██% | $3.24B | -x |
| Biogen Inc. | BIIB | ██% | $29.35B | 21.4x |
| Biontech Se | BNTX | ██% | $23.69B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $592M | -x |
| Candel Therapeutics, Inc. | CADL | ██% | $639M | -x |
| C4 Therapeutics, Inc. | CCCC | ██% | $330M | -x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1.0x |
| Creative Medical Technology … | CELZ | ██% | $8M | -x |
| Cero Therapeutics Holdings, … | CERO | ██% | $1M | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $992M | -x |
| Compugen Ltd | CGEN | ██% | $268M | 3.8x |
| Cg Oncology, Inc. | CGON | ██% | $6.34B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $105M | -x |
| Coherus Oncology, Inc. | CHRS | ██% | $264M | 1.4x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $3M | -x |
| Cellectis S.A. | CLLS | ██% | $398M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $337M | -x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1.5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $112M | -x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $151M | -x |
| Curis Inc | CRIS | ██% | $22M | -x |
| Crispr Therapeutics Ag | CRSP | ██% | $5.09B | -x |
| Champions Oncology, Inc. | CSBR | ██% | $87M | -x |
| Cel Sci Corp | CVM | ██% | $10M | -x |
| Dbv Technologies S.A. | DBVT | ██% | $1.18B | -x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $514M | -x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.09B | -x |
| Precision Biosciences Inc | DTIL | ██% | $212M | -x |
| Dyadic International Inc | DYAI | ██% | $26M | -x |
| Editas Medicine, Inc. | EDIT | ██% | $287M | -x |
| Eloxx Pharmaceuticals, Inc. | ELOX | ██% | $20K | -x |
| Elutia Inc. | ELUT | ██% | $49M | 0.9x |
| Engene Therapeutics Inc. | ENGN | ██% | $96M | -x |
| Entera Bio Ltd. | ENTX | ██% | $68M | -x |
| Viskase Holdings, Inc. | ENZN | ██% | $42M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $52M | -x |
| Evaxion A/S | EVAX | ██% | $35M | -x |
| Exelixis, Inc. | EXEL | ██% | $12.55B | 15.1x |
| Exozymes Inc. | EXOZ | ██% | $83M | -x |
| Fate Therapeutics Inc | FATE | ██% | $260M | -x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $540M | -x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $240M | -x |
| Finch Therapeutics Group, … | FNCH | ██% | $12M | 0.5x |
| Finch Therapeutics Group, … | FNCHQ | ██% | $12M | 0.5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $167.60B | 18.2x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.61B | -x |
| Genenta Science S.P.A. | GNTA | ██% | $14M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Greenland Mines Ltd | GRML | ██% | $51M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $8.41B | 24.1x |
| Humacyte, Inc. | HUMA | ██% | $202M | -x |
| Immunitybio, Inc. | IBRX | ██% | $8.50B | -x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $254M | -x |
| Imagenebio, Inc. | IMA | ██% | $65M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.49B | -x |
| Immatics N.V. | IMTX | ██% | $1.53B | -x |
| Immunovant, Inc. | IMVT | ██% | $5.83B | -x |
| In8bio, Inc. | INAB | ██% | $16M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6.8x |
| Mink Therapeutics, Inc. | INKT | ██% | $57M | -x |
| Inmune Bio, Inc. | INMB | ██% | $37M | -x |
| Intensity Therapeutics, Inc. | INTS | ██% | $12M | -x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.56B | -x |
| Century Therapeutics, Inc. | IPSC | ██% | $413M | -x |
| Invivyd, Inc. | IVVD | ██% | $420M | -x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $26M | -x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $110M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.45B | -x |
| Krystal Biotech, Inc. | KRYS | ██% | $9.13B | 40.6x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.87B | -x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $619M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $332M | -x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $248M | -x |
| Atyr Pharma Inc | LIFE | ██% | $1.61B | -x |
| Liminatus Pharma, Inc. | LIMN | ██% | $9M | -x |
| Leonabio, Inc. | LONA | ██% | $96M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $422M | -x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.28B | -x |
| Mesoblast Ltd | MESO | ██% | $1.87B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $906M | -x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $51M | -x |
| Molecular Partners Ag | MOLN | ██% | $163M | -x |
| Moderna, Inc. | MRNA | ██% | $21.15B | -x |
| Neurocrine Biosciences Inc | NBIX | ██% | $15.67B | 23.4x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0.1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $342M | -x |
| Novavax Inc | NVAX | ██% | $1.58B | -x |
| Ocugen, Inc. | OCGN | ██% | $497M | -x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $29M | -x |
| Palisade Bio, Inc. | PALI | ██% | $321M | -x |
| Passage Bio, Inc. | PASG | ██% | $16M | -x |
| Vaxcyte, Inc. | PCVX | ██% | $7.80B | -x |
| Biomx Inc. | PHGE | ██% | $6M | -x |
| Pluri Inc. | PLUR | ██% | $35M | -x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $154M | -x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $8M | -x |
| Prime Medicine, Inc. | PRME | ██% | $596M | -x |
| Prokidney Corp. | PROK | ██% | $537M | -x |
| Pelthos Therapeutics Inc. | PTHS | ██% | $88M | -x |
| Qiagen N.V. | QGEN | ██% | $7.31B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $21M | 2.4x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $326M | -x |
| Repligen Corp | RGEN | ██% | $6.41B | 124.7x |
| Regenxbio Inc. | RGNX | ██% | $521M | -x |
| Relay Therapeutics, Inc. | RLAY | ██% | $2.45B | -x |
| Revolution Medicines, Inc. | RVMD | ██% | $29.17B | -x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.67B | -x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $254M | -x |
| Sana Biotechnology, Inc. | SANA | ██% | $880M | -x |
| Scilex Holding Co | SCLX | ██% | $48M | -x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $58M | -x |
| Solid Biosciences Inc. | SLDB | ██% | $760M | -x |
| Silexion Therapeutics Corp | SLXN | ██% | $2M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $30M | -x |
| Scholar Rock Holding … | SRRK | ██% | $5.86B | -x |
| Surrozen, Inc./De | SRZN | ██% | $352M | -x |
| Sutro Biopharma, Inc. | STRO | ██% | $678M | -x |
| Protara Therapeutics, Inc. | TARA | ██% | $284M | -x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.53B | -x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $74M | -x |
| Bio-Techne Corp | TECH | ██% | $7.42B | 67.7x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $530M | -x |
| Instil Bio, Inc. | TIL | ██% | $55M | -x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $211M | -x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3.5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.93B | -x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0.5x |
| Tevogen Bio Holdings … | TVGN | ██% | $29M | -x |
| Twist Bioscience Corp | TWST | ██% | $3.33B | -x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $387M | 43.1x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6.7x |
| Valneva Se | VALN | ██% | $579M | -x |
| Vericel Corp | VCEL | ██% | $1.69B | 78.9x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.49B | -x |
| Vivosim Labs, Inc. | VIVS | ██% | $3M | -x |
| Vor Biopharma Inc. | VOR | ██% | $856M | -x |
| Vaxart, Inc. | VXRT | ██% | $164M | 4.4x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $251M | -x |
| Windtree Therapeutics Inc … | WINT | ██% | $560K | -x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $398M | -x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $18M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $14M | -x |
| Zura Bio Ltd | ZURA | ██% | $446M | -x |
よくあるご質問
-
Relay Therapeutics, Inc.は買いの銘柄ですか？
当社のAIはRelay Therapeutics, Inc.を毎日分析しています。上記のシグナルで最新の推奨をご確認ください。投資前には必ずご自身で調査を行ってください。
-
Relay Therapeutics, Inc.の予測精度はどの程度ですか？
当社のAIはこの銘柄で23%のスピアマン相関を達成しており、毎日分析される4,000以上の銘柄で平均67%以上の精度です。
-
予測はどのくらいの頻度で更新されますか？
Relay Therapeutics, Inc.の予測は最新の市場データとAIモデルを使用して毎日更新されます。
Relay Therapeutics, Inc.のより深い分析をお探しですか？
Intratioで機関投資家レベルの完全な分析を表示 →AI予測は過去のパターンに基づいており、投資判断の唯一の根拠とすべきではありません。過去の実績は将来の結果を保証するものではありません。必ずご自身で調査を行ってください。